LetterJAMA psychiatryPublished
Esketamine for Treatment-Resistant Depression-Reply
Janik A, Shelton RC, Fu DJ
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Mercer County
Publication record
- Type
- Letter
- Venue
- JAMA psychiatry
- Published
- Topic
- Clinical care
- PubMed ID
- 41191340
- Added to directory
- Source checked
Similar research in the Delaware Valley
Publications, clinical studies and software from the region that share this record’s distinctive subject words. Use them to see who else in the region works on the subject.
-
ArticleNeurology and therapy
Profiles of Medicaid Beneficiaries with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray
Clemens K, Zhdanava M, Teeple A and others (9 authors)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Case reportInnovations in clinical neuroscience
Intranasal Esketamine in Patients with Treatment-resistant Depression Who Have Previously Failed Transcranial Magnetic Stimulation: A Case Series
Ahmad R, Shor S, Aickareth G and others (8 authors)
Verified Author affiliations on the Europe PMC record name Cooper Norcross Health, Cooper Medical School of Rowan University, Rowan University. Affiliation source
Clinical careAdded
-
Interventional trialNCT05554627Withdrawn
VA Aripiprazole vs Esketamine for Treatment Resistant Depression
Philadelphia County · ClinicalTrials.gov
Added
-
Interventional trialNCT04599855Completed
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
Philadelphia County · ClinicalTrials.gov
Added
-
Clinical trial reportCNS spectrums
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery-Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire
Kern Sliwa J, Naranjo RR Jr, Turkoz I and others (6 authors)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportJAMA psychiatry
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial
Janik A, Qiu X, Lane R and others (11 authors)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
Recent clinical care publications from Johnson & Johnson
More from this institution-
Clinical trial reportBlood advances
Teclistamab and daratumumab immune-based doublet therapy for relapsed/refractory multiple myeloma: the TRIMM-2 study
Rodríguez-Otero P, Morillo D, D'Souza A and others (30 authors)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewRheumatology and therapy
Humanistic Burden of Sjögren's Disease: A Systematic Review of Treatment Efficacy on Health-Related Quality of Life
Akpek EK, Adamson E, Shea L and others (10 authors)
Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, University of Pennsylvania, with Drexel University linked by the institution reference. Affiliation source
Clinical careAdded
-
ArticleCurrent medical research and opinion
Disease burden among patients with generalized myasthenia gravis in the United States receiving standard of care therapy: the patient perspective
Pesa J, Jackson L, Keenan A and others (9 authors)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Modeling Long-Term Progression-Free Survival in Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone
Sonneveld P, Zweegman S, Facon T and others (19 authors)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleAntiviral therapy
Liver concentrations of JNJ-73763989 siRNA triggers in patients with chronic hepatitis B (CHB): The INSIGHT study panel 3 results
Asselah T, Vilgrain V, Kakuda TN and others (11 authors)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded